US81728J1097 - Common Stock
SENSUS HEALTHCARE INC
NASDAQ:SRTS (5/31/2024, 7:07:12 PM)
After market: 5.45 +0.03 (+0.55%)5.42
-0.24 (-4.24%)
Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company is headquartered in Boca Raton, Florida and currently employs 42 full-time employees. The company went IPO on 2016-06-03. The firm is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. The firm uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The firm incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. Its SRT-100+ offers remote diagnostics solutions, including operation tracking.
SENSUS HEALTHCARE INC
851 Broken Sound Pkwy NW Ste 215
Boca Raton FLORIDA 33487
P: 15619225808
CEO: Joseph C. Sardano
Employees: 42
Website: https://sensushealthcare.com/
Let's explore the current happenings on the US markets on Monday. Below, you'll find the stocks exhibiting unusual volume in today's session.
The biggest pre-market stock movers are ready to go as we check out all of the hottest news happening on Friday morning!
SRTS stock results show that Sensus Healthcare beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Sensus Healthcare (NASDAQ:SRTS) just reported results for the first quarter of ...
Revenues of $10.7 million, compared with $3.4 million in the prior-year quarter; Adjusted EBITDA (a non-GAAP measure) of $3.0 million, compared with...
Here you can normally see the latest stock twits on SRTS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: